Ai Changkang® won the first prize of the 2022 Invention Venture Award Award

Recently, the China Invention Association announced the list of the third invention and entrepreneurship awards. Wuhan Emisen Life Technology Co., Ltd. "The Development and Application and Application of Effective Thorns DNA Beetal Testing Kit" of the "Double Target of Colorectal Cancer" project won the first prize of the 3rd "Invention and Entrepreneurship Award" of the China Invention Association in 2022.

This year's selection was nominated for more than 1,400 outstanding innovation projects such as the chairman, academician, innovative enterprises and universities, and universities and universities. 117 awards and 134 second prizes). The invention and entrepreneurial achievement award is benchmarking the National Science and Technology Progress Award. The award -winning project is expected to be nominated for the National Science and Technology Award of the Chinese Invention Association.

The invention and entrepreneurial award was approved by the Ministry of Science and Technology in 2005. It was established by the China Invention Association. It is the first national award for the inventor. The selection of awards is supported by the Ministry of Science and Technology, the National Federation of Trade Unions, the National Intellectual Property Office and other agencies and ministries and commissions. Laupate a strong social foundation for the vigorous promotion of independent scientific and technological innovation and contribute to the construction of innovative countries. The invention of the entrepreneurial award is composed of four awards, including character prize, results award, innovation award, and project award.

The award -winning project "Double target of colorectal cancer, high -efficiency non -invasive feces DNA methylation detection kit development and application" is the world's first SDC2/TFPI2 dual -target tidal colorectal cancer feces DNA methylation testing kit -Ai Changkang Kangkang Kangkang ®, for the differences in the left and right colon, the SDC2 gene methylation has higher sensitivity to the right colon tumor. The detection sensitivity increased to 95.3%, avoid leakage, while maintaining high -specific (90.3%), and increased the detection sensitivity of adenoma to 63.4%.

National Inspection 20223400373

Ai Changkang® optimizes technical optimization in multiple key steps and process automation in sample pre -processing, nucleic acid extraction, nucleic acid transformation, PCR detection, etc., and can complete a single sample detection in 4.5 hours, and can process up to 96 samples at a time. Ai Changkang® uses exclusive trace signal enrichment technology (AS-CAP) and methylized PCR sensitization technology to reduce the required sample suspension to 1.8 ml. Quickly complete the high -throughput detection task.

SDC2 and TFPI2 gene methylization joint test (Ai Changkang®) registered clinical research on clinical research. Five studies related articles were published in authoritative journals such as Front Mol Biosci and J Mol Diagn. The scientific and technological achievement registration certificate obtained by the Ministry of Industry and Information Technology has reached the international advanced level by the evaluation of many experts.

Source: Jingbao.com

- END -